• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, S.A. VIDAS® FT4 ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, S.A. VIDAS® FT4 ASSAY Back to Search Results
Catalog Number 30459
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/14/2018
Event Type  malfunction  
Event Description
A customer in (b)(6) reported falsely under-estimated results for two patients in association with the vidas® ft4 assay (lot 1002011310) and a tsh (thyroid) panel on (b)(6) 2018.Each patient sample was tested on two different lots of the ft4 (free thyroxine) assay.The customer stated the calibrations were correct.The euthyroid reference range for ft4 is [0.82-1.5] ng/dl.The results were: patient 1: tsh 1.14 uiu/ml [0.25-5].Ft4 : 0.81 ng/dl (2301 rfv) other lot.Ft4 : 0.14 ng/dl (3227 rfv) lot 1002011310 - too low.Patient 2: tsh 0.84 uiu/ml [0.25-5].Ft4 : 1.36 ng/dl (1794 rfv) other lot.Ft4 : 0.46 ng/dl (2370 rfv) lot 1002011310 - too low.The customer did not report the results for lot 1002011310, but reported results from a different lot.There was no impact on the patients' treatment and there was no delay.A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
Maquet medical systems,usa(importer)submits this report on behalf of the legal manufacturer of the device maquet cardiopulmonary ag kehler strasse 31, 76437 rastatt, germany.A follow-up medwatch will be submitted when additional information becomes available.Reference exemption # e2018002.Importer: maquet medical systems usa (b)(4).Contact person: (b)(6).The product is not available for investigation in the laboratory of manufacturer.Maquet cardiopulmonary is aware of a similar complaint(703006748) which was investigated as follows:the returned complaint sample was after rinsing with water and a cleaning with sodium hypochlorite,a visual inspection and a leak test according to lv 201(blood side) performed.The leak test according to lv 201(blood side)was performed and on the blood outlet connector(1/4 connector)a leak(cracks) was detected.The cracks could be occurred during return of the device,because the customer did not noticed a leakage on the connector during use.The reported leakage on the disconnector port could be confirmed.Affected product:packaging lot #70117380 and production lot 70117377-70117380,udi-number (b)(4).The avz from (b)(4) (dms# (b)(4)) was reviewed.There were no references found,which are indicating a nonconformance of the product in question.Sap trend search was performed(material 70106.7948,failure code 0104 dialysis lock and valve) which came to following results:2 additional complaints were recorded in last 12 months.Based on the sales figures of the last 12 months following occurrence rate has been calculated:0,1%, which is below 1%.Due to this information no systemic issue could be determined.The failure is already known to the manufacturer and has been thoroughly investigated under capa 17-07-003.The most probable cause of the reported failure is the detected offset which caused a leakage of the o-ring.All further steps will be performed in accordance to capa 17-07-003.
 
Manufacturer Narrative
An internal biomérieux investigation was performed with results as follows: the reagent vidas® ft4n, and batch number 180924-0 is within the expected performances of the product.The customer's anomaly could not be reproduced on the six (6) samples tested internally.Without returned samples it is not possible to investigate further.Vidas® ft4 result should be interpreted in conjunction with other parameter results (such as tsh) patient clinical context and history, as indicated in the package insert, page 1 (vidas ft4 ref 30459): "the vidas® ft4 test aids in diagnosing thyroid disorders.The ft4 assay must be used in conjunction with other tests, such as tsh, as well as a clinical examination of the patient (4)." it is necessary to perform regular instrument maintenance in order to ensure the mini vidas®, vidas® and vidas 3® are functioning correctly and ensure the quality of your daily results.These procedures are described in the mini vidas®, vidas® or vidas 3® user manuals.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® FT4 ASSAY
Type of Device
VIDAS® FT4 ASSAY
Manufacturer (Section D)
BIOMERIEUX, S.A.
chemin de l orme
marcy l etoile, rhone 69280
FR  69280
MDR Report Key7596023
MDR Text Key111436297
Report Number3002769706-2018-00078
Device Sequence Number1
Product Code CEC
Combination Product (y/n)N
PMA/PMN Number
K132058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 09/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/24/2018
Device Catalogue Number30459
Device Lot Number1006011310
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 05/16/2018
Initial Date FDA Received06/13/2018
Supplement Dates Manufacturer Received08/09/2018
08/09/2018
Supplement Dates FDA Received09/07/2018
09/07/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-